miR-101 suppresses tumor proliferation and migration, and induces apoptosis by targeting EZH2 in esophageal cancer cells

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 10, 2014, Pages 6543-6550

  Lin, Chen ^a   Huang, Fei ^a   Li, Qiao Zhi ^a   Zhang, Ya Jing ^b  

^a XINJIANG MEDICAL UNIVERSITY   (China)

^b Department of Pathology The Forth Affiliated Hospital   (China)

Author keywords

ESCC; EZH2; Invasion; MiR 101; Proliferation

Indexed keywords

EZH2 PROTEIN, HUMAN; MICRORNA; MIRN101 MICRORNA, HUMAN; POLYCOMB REPRESSIVE COMPLEX 2;

APOPTOSIS; CELL MOTION; CELL PROLIFERATION; DOWN REGULATION; ESOPHAGUS TUMOR; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TIME; TUMOR CELL LINE; TUMOR INVASION;

APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; POLYCOMB REPRESSIVE COMPLEX 2; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION;

EID: 84912104884     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med 2003; 349: 2241-52.
2. Qi YJ, Chao WX, Chiu JF. An overview of esophageal squamous cell carcinoma proteomics. J Proteomics 2012; 75: 3129-37.
3. Gamliel Z, Krasna MJ. Multimodality treatment of esophageal cancer. Surg Clin North Am 2005; 85: 621-30.
4. Xie F, Li K, Ouyang X. Twist, an independent prognostic marker for predicting distant metastasis and survival rates of esophageal squamous cell carcinoma patients. Clin Exp Metastasis 2009; 26: 1025-32.
5. Wang X, Tian X, Liu F, Zhao Y, Sun M, Chen D, Lu C, Wang Z, Shi X, Zhang Q, Zhang D, Shen Z, Li F, Harris CC, Cai H, Ke Y. Detection of HPV DNA in esophageal cancer specimens from different regions and ethnic groups: a descriptivestudy. BMC Cancer 2010; 10: 19:1-8
6. Zhang Y, Yang PY, Wang XF. Microenvironmental regulation of cancer metastasis by miRNAs. Trends Cell Biol 2014; 24: 153-160.
7. Lin RJ, Xiao DW, Liao LD, Chen T, Xie ZF, Huang WZ, Wang WS, Jiang TF, Wu BL, Li EM, Xu LY. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma. J Surg Oncol 2012; 105: 175-82.
8. Zhang MX, Yang Q, Zhang LM, Zhou SN, Ye WG, Yao QL, Li ZF, Huang C, Wen QS and Wang JJ. miR-302b is a potential molecular marker of esophageal squamous cell carcinoma and functions as a tumor suppressor by targeting ErbB4. J Exp Clin Cancer Res 2014; 33: 10.
9. Wu C, Li M, Hu C, Duan H. Clinical significance of serum miR-223, miR-25 and miR-375 in patients with esophageal squamous cell carcinoma. Mol Biol Rep 2014; 41: 1257-66.
10. Wang Y, Zang W, Du Y, Ma Y, Li M, Li P, Chen X, Wang T, Dong Z, Zhao G. Mir-655 up-regulation suppresses cell invasion by targeting pituitary tumor-transforming gene-1 in esophageal squamous cell carcinoma. J Transl Med 2013; 11: 301.
11. Yin J, Wang X, Zheng L, Shi Y, Wang L, Shao A, Tang W, Ding G, Liu C, Liu R, Chen S, Gu H. Hsa-miR-34b/c rs4938723 T>C and hsa-miR-423 rs6505162 C>A polymorphisms are associated with the risk ofesophageal cancer in a Chinese population. PLoS One 2013; 8: e80570.
12. Strillacci A, Valerii MC, Sansone P, Caggiano C, Sgromo A, Vittori L, Fiorentino M, Poggioli G, Rizzello F, Campieri M, Spisni E. Loss of miR-101 expression promotes Wnt/ß-catenin signalling pathway activation and malignancy in colon cancer cells. J Pathol 2013; 229: 379-389.
13. Hao Y, Gu X, Zhao Y, Greene S, Sha W, Smoot DT, Califano J, Wu TC, Pang X. Enforced expression of miR-101 inhibits prostate cancer cell growth by modulating the COX-2 pathway in vivo. Cancer Prev Res (Phila) 2011; 4: 1073-83.
14. Lin C, Huang F, Zhang YJ, Tuokan T, Kuerban G. Roles of MiR-101 and its target gene Cox-2 in early diagnosis of cervical cancer of uygur women. Asian Pac J Cancer Prev 2014; 15: 45-48.
15. Semaan A, Qazi AM, Seward S, Chamala S, Bryant CS, Kumar S, Morris R, Steffes CP, Bouwman DL, Munkarah AR, Weaver DW, Gruber SA, Batchu RB. MicroRNA-101 inhibits growth of epithelial ovarian cancer by relieving chromatin-mediated transcriptional Repression of p21(waf1/cip1). Pharm Res 2013; 28: 3079-3090.
16. Hu Z, Lin Y, Chen H, Mao Y, Wu J, Zhu Y, Xu X, Xu X, Li S, Zheng X, Xie L. MicroRNA-101 suppresses motility of bladder cancer cells by targeting c-Met. Biochem Biophys Res Commun 2013; 435: 82-87.
17. Zhang Y, Guo X, Xiong L, Kong X, Xu Y, Liu C, Zou L, Li Z, Zhao J, Lin N. MicroRNA-101 suppresses SOX9-dependent tumorigenicity and promotes favorable prognosis of human hepatocellular carcinoma. FEBS Lett 2012; 586: 4362-4370.
18. Huang F, Lin C, Shi YH, Kuerban G. MicroRNA-101 inhibits cell proliferation,invasion,and promotes apoptosis by regulating cyclooxygenase-2 in hela cervical carcinoma cells. Asian Pac J Cancer Prev 2013; 14: 5915-5920.
19. Zhang Y, Guo X, Xiong L, Kong X, Xu Y, Liu C, Zou L, Li Z, Zhao J, Lin N. MicroRNA-101 suppresses SOX9-dependent tumorigenicity and promotes favorable prognosis of human hepatocellular carcinoma. FEBS Lett 2012; 586: 4362-70.
20. Cho HM, Jeon HS, Lee SY, Jeong KJ, Park SY, Lee HY, Lee JU, Kim JH, Kwon SJ, Choi E, Na MJ, Kang J, Son JW. microRNA-101 inhibits lung cancer invasion through the regulation of enhancer of zeste homolog 2. Exp Ther Med 2011; 2: 963-967.